Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
Titel:
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
Auteur:
Felip, E. Shaw, A.T. Bearz, A. Camidge, D.R. Solomon, B.J. Bauman, J.R. Bauer, T.M. Peters, S. Toffalorio, F. Abbattista, A. Thurm, H. Peltz, G. Wiltshire, R. Besse, B.